FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008610318> ?p ?o ?g. }

• W2008610318 endingPage "997" @default.
• W2008610318 startingPage "991" @default.
• W2008610318 abstract "Background Avian influenza A virus H5N1 has caused widespread infections that have resulted in severe disease or death in poultry and wild birds as well as human beings. This virus has the potential to emerge as a pandemic threat and H5N1 vaccines are being developed in many countries. Our aim was to assess the safety and immunogenicity of an inactivated adjuvanted whole-virion H5N1 vaccine. Methods A stratified randomised, placebo-controlled, double-blind phase I clinical trial was done in 120 volunteers aged 18–60 years. Volunteers were assigned to receive two doses of placebo (n=24) or an inactivated whole-virion influenza A (H5N1) vaccine with 1·25 μg (24), 2·5 μg (24), 5 μg (24), or 10 μg (24) haemagglutinin per dose with aluminium hydroxide adjuvant on day 0 and 28. Serum samples were obtained on day 0, 14, 28, 42, and 56 for haemagglutination inhibition and virus neutralisation assays. This trial is registered with the ClinicalTrials.gov registry with the number NCT00356798. Findings All four formulations of vaccines were well tolerated. No serious adverse event was reported and most local and systemic reactions were mild and transient. All formulations induced antibody responses after the first dose; the highest immune response of 78% seropositivity was seen in the 10 μg group after two vaccine doses. Two individuals dropped out: one in the 1·25 μg group (withdrew consent) and one in the 10 μg group (discontinued); one individual was also excluded from the final analysis. Interpretation A two-dose regimen of an adjuvanted 10 μg inactivated whole-virion H5N1 vaccine met all European regulatory requirements for annual licensing of seasonal influenza vaccine. Lower doses of this vaccine could achieve immune responses equivalent to those elicited by adjuvanted or non-adjuvanted split-virion vaccines. The use of a whole virion vaccine could be more adaptable to the antigen-sparing strategy recommended by WHO for protection against an influenza pandemic." @default.
• W2008610318 created "2016-06-24" @default.
• W2008610318 creator A5004698472 @default.
• W2008610318 creator A5009874715 @default.
• W2008610318 creator A5011643810 @default.
• W2008610318 creator A5021293751 @default.
• W2008610318 creator A5031598540 @default.
• W2008610318 creator A5032761915 @default.
• W2008610318 creator A5033914694 @default.
• W2008610318 creator A5034757601 @default.
• W2008610318 creator A5037270893 @default.
• W2008610318 creator A5038937443 @default.
• W2008610318 creator A5041762848 @default.
• W2008610318 creator A5043859457 @default.
• W2008610318 creator A5049562237 @default.
• W2008610318 creator A5056101043 @default.
• W2008610318 creator A5065210006 @default.
• W2008610318 creator A5068206764 @default.
• W2008610318 creator A5072550199 @default.
• W2008610318 creator A5079594267 @default.
• W2008610318 creator A5080592111 @default.
• W2008610318 creator A5080625732 @default.
• W2008610318 creator A5090424198 @default.
• W2008610318 date "2006-09-01" @default.
• W2008610318 modified "2023-09-26" @default.
• W2008610318 title "Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial" @default.
• W2008610318 cites W1969287126 @default.
• W2008610318 cites W2002862439 @default.
• W2008610318 cites W2027741520 @default.
• W2008610318 cites W2034382342 @default.
• W2008610318 cites W2036596307 @default.
• W2008610318 cites W2038964902 @default.
• W2008610318 cites W2048375908 @default.
• W2008610318 cites W2059497826 @default.
• W2008610318 cites W2065102424 @default.
• W2008610318 cites W2090540879 @default.
• W2008610318 cites W2114555019 @default.
• W2008610318 cites W2130490068 @default.
• W2008610318 cites W2131170401 @default.
• W2008610318 cites W2274519842 @default.
• W2008610318 cites W2615766024 @default.
• W2008610318 doi "https://doi.org/10.1016/s0140-6736(06)69294-5" @default.
• W2008610318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16980114" @default.
• W2008610318 hasPublicationYear "2006" @default.
• W2008610318 type Work @default.
• W2008610318 sameAs 2008610318 @default.
• W2008610318 citedByCount "250" @default.
• W2008610318 countsByYear W20086103182012 @default.
• W2008610318 countsByYear W20086103182013 @default.
• W2008610318 countsByYear W20086103182014 @default.
• W2008610318 countsByYear W20086103182015 @default.
• W2008610318 countsByYear W20086103182016 @default.
• W2008610318 countsByYear W20086103182017 @default.
• W2008610318 countsByYear W20086103182018 @default.
• W2008610318 countsByYear W20086103182019 @default.
• W2008610318 countsByYear W20086103182021 @default.
• W2008610318 crossrefType "journal-article" @default.
• W2008610318 hasAuthorship W2008610318A5004698472 @default.
• W2008610318 hasAuthorship W2008610318A5009874715 @default.
• W2008610318 hasAuthorship W2008610318A5011643810 @default.
• W2008610318 hasAuthorship W2008610318A5021293751 @default.
• W2008610318 hasAuthorship W2008610318A5031598540 @default.
• W2008610318 hasAuthorship W2008610318A5032761915 @default.
• W2008610318 hasAuthorship W2008610318A5033914694 @default.
• W2008610318 hasAuthorship W2008610318A5034757601 @default.
• W2008610318 hasAuthorship W2008610318A5037270893 @default.
• W2008610318 hasAuthorship W2008610318A5038937443 @default.
• W2008610318 hasAuthorship W2008610318A5041762848 @default.
• W2008610318 hasAuthorship W2008610318A5043859457 @default.
• W2008610318 hasAuthorship W2008610318A5049562237 @default.
• W2008610318 hasAuthorship W2008610318A5056101043 @default.
• W2008610318 hasAuthorship W2008610318A5065210006 @default.
• W2008610318 hasAuthorship W2008610318A5068206764 @default.
• W2008610318 hasAuthorship W2008610318A5072550199 @default.
• W2008610318 hasAuthorship W2008610318A5079594267 @default.
• W2008610318 hasAuthorship W2008610318A5080592111 @default.
• W2008610318 hasAuthorship W2008610318A5080625732 @default.
• W2008610318 hasAuthorship W2008610318A5090424198 @default.
• W2008610318 hasConcept C126322002 @default.
• W2008610318 hasConcept C133239900 @default.
• W2008610318 hasConcept C142724271 @default.
• W2008610318 hasConcept C159047783 @default.
• W2008610318 hasConcept C159654299 @default.
• W2008610318 hasConcept C197934379 @default.
• W2008610318 hasConcept C203014093 @default.
• W2008610318 hasConcept C204787440 @default.
• W2008610318 hasConcept C22070199 @default.
• W2008610318 hasConcept C2522874641 @default.
• W2008610318 hasConcept C27081682 @default.
• W2008610318 hasConcept C2776872762 @default.
• W2008610318 hasConcept C2777863537 @default.
• W2008610318 hasConcept C2780689484 @default.
• W2008610318 hasConcept C2780868878 @default.
• W2008610318 hasConcept C2781413609 @default.
• W2008610318 hasConcept C519248777 @default.
• W2008610318 hasConcept C71924100 @default.
• W2008610318 hasConceptScore W2008610318C126322002 @default.
• W2008610318 hasConceptScore W2008610318C133239900 @default.

• next